The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.
Interpreting a covid-19 test result
Open accessAbstract
What you need to know• Interpreting the result of a test for covid-19 depends on two things: the accuracy of the test, and the pre-test probability or estimated risk of disease before testing • A positive RT-PCR test for covid-19 test has more weight than a negative test because of the test's high specificity but moderate sensitivity • A single negative covid-19 test should not be used as a rule-out in patients with strongly suggestive symptoms • Clinicians should share information with patients about the accuracy of covid-19 testsAcross the world there is a clamour for covid-19 testing, with Tedros Adhanom Ghebreyesus, director general of the World Health Organization, encouraging countries to "test, test, test." 1 The availability of the complete genome of covid-19 early in the epidemic facilitated development of tests to detect viral RNA. 2 Multiple assays with different gene targets have been developed using reverse transcriptase polymerase chain reaction (RT-PCR).3 These viral RNA tests use samples usually obtained from the respiratory tract by nasopharyngeal swab, to detect current infections.Serology blood tests to detect antibodies indicating past infection are being developed; these will not be considered in depth in this article.Testing for covid-19 enables infected individuals to be identified and isolated to reduce spread, 4 allows contact tracing for exposed individuals, 5 and provides knowledge of regional and national rates of infection to inform public health interventions.However, questions remain on how to apply test results to make optimal decisions about individual patients. Search strategyThis article was produced at speed to address an urgent need to address uncertainties in testing for covid-19.We searched Pubmed using the terms "covid", "SARS-CoV-2", "sensitivity", "specificity", "diagnosis", "test", and "PCR", and KSR evidence using terms for covid and test.This was supplemented by discussion with colleagues undertaking formal systematic reviews into covid-19 diagnosis.Practice PRACTICE 10.1136/
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR
Corman, V. M., Landt, O., Kaiser, M., Molenkamp, R., Meijer, A., Chu, D. K., Bleicker, T., Brünink, S., Schneider, J., Schmidt, M. L., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.3.2000045 · Cited by 7,344
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Detection of SARS-CoV-2 in Different Types of Clinical Specimens
Wang, W., Xu, Y., Gao, R., Lu, R., Han, K., Wu, G., & Tan, W. (2020) · JAMA · doi:10.1001/jama.2020.3786 · Cited by 5,028
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Zhao, J., Yuan, Q., Wang, H., Liu, W., Liao, X., Su, Y., Wang, X., Yuan, J., Li, T., Li, J., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa344 · Cited by 2,607
Li, Z., Yi, Y., Luo, X., Xiong, N., Liu, Y., Li, S., Sun, R., Wang, Y., Hu, B., Chen, W., et al. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25727 · Cited by 1,771
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa310 · Cited by 1,587
Interpreting Diagnostic Tests for SARS-CoV-2
Sethuraman, N., Jeremiah, S. S., & Ryo, A. (2020) · JAMA · doi:10.1001/jama.2020.8259 · Cited by 1,494
Chan, J. F.-W., Yip, C. C.-Y., To, K. K.-W., Tang, T. H.-C., Wong, S. C.-Y., Leung, K.-H., Fung, A. Y.-F., Ng, A. C.-K., Zou, Z., Tsoi, H.-W., et al. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00310-20 · Cited by 880
Interpretation by Physicians of Clinical Laboratory Results
Casscells, W., Schoenberger, A., & Graboys, T. B. (1978) · New England Journal of Medicine · doi:10.1056/nejm197811022991808 · Cited by 755
Covid-19: identifying and isolating asymptomatic people helped eliminate virus in Italian village
Day, M. (2020) · BMJ · doi:10.1136/bmj.m1165 · Cited by 409
Developing antibody tests for SARS-CoV-2
Petherick, A. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30788-1 · Cited by 359
The spectrum effect in tests for risk prediction, screening, and diagnosis
Usher-Smith, J. A., Sharp, & Griffin, S. J. (2016) · BMJ · doi:10.1136/bmj.i3139 · Cited by 250
Covid-19: why is the UK government ignoring WHO’s advice?
Pollock, A. M., Roderick, P., Cheng, K. K., & Pankhania, B. (2020) · BMJ · doi:10.1136/bmj.m1284 · Cited by 56
Cited by
Characterizing long COVID in an international cohort: 7 months of symptoms and their impact
Davis, H. E., Assaf, G. S., McCorkell, L., Wei, H., Low, R. J., Re'em, Y., Redfield, S., Austin, J. P., & Akrami, A. (2021) · eClinicalMedicine · doi:10.1016/j.eclinm.2021.101019 · Cited by 2,881
False Negative Tests for SARS-CoV-2 Infection — Challenges and Implications
Woloshin, S., Patel, N., & Kesselheim, A. S. (2020) · New England Journal of Medicine · doi:10.1056/nejmp2015897 · Cited by 803
Hodgson, S. H., Mansatta, K., Mallett, G., Harris, V., Emary, K. R. W., & Pollard, A. J. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30773-8 · Cited by 633
Preexisting Comorbidities Predicting COVID-19 and Mortality in the UK Biobank Community Cohort
Atkins, J. L., Masoli, J. A. H., Delgado, J., Pilling, L. C., Kuo, C.-L., Kuchel, G. A., & Melzer, D. (2020) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glaa183 · Cited by 498
Diagnostics for COVID-19: moving from pandemic response to control
Peeling, R. W., Heymann, D. L., Teo, Y.-Y., & Garcia, P. J. (2022) · The Lancet · doi:10.1016/s0140-6736(21)02346-1 · Cited by 486
Metadata
- Authors
- Watson, J., Whiting, P. F., & Brush, J. E.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2020-05-12
- Volume
- 369
- Pages
- m1808
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3025391403
- Cited by
- 712
- References
- 13
- FWCI
- 20.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.